Author Topic: This Bıdɛn Proposal Could Make the US a “Digital Dictatorship”  (Read 117 times)

0 Members and 1 Guest are viewing this topic.

Offline Mr G

  • Full Member
  • ***
  • Posts: 1652
  • Reputation: +953/-75
  • Gender: Male
This Bıdɛn Proposal Could Make the US a “Digital Dictatorship” - unlimitedhangout.com

Go to link for the full article.


Last Wednesday, President Bıdɛn was widely praised in mainstream and health-care–focused media for his call to create a “new biomedical research agency” modeled after the US military’s “high-risk, high-reward” Defense Advanced Research Projects Agency, or DARPA. As touted by the president, the agency would seek to develop “innovative” and “breakthrough” treatments for cancer, Alzheimer’s disease, and diabetes, with a call to “end cancer as we know it.”  

Far from “ending cancer” in the way most Americans might envision it, the proposed agency would merge “national security” with “health security” in such as way as to use both physical and mental health “warning signs” to prevent outbreaks of disease or violence before they occur. Such a system is a recipe for a technocratic “pre-crime” organization with the potential to criminalize both mental and physical illness as well as “wrongthink.”

The Bıdɛn administration has asked Congress for $6.5 billion to fund the agency, which would be largely guided by Bıdɛn’s recently confirmed top science adviser, Eric Lander. Lander, formerly the head of the Silicon Valley–dominated Broad Institute, has been controversial for his ties to eugenicist and child sex trafficker Jeffrey Epstein and his relatively recent praise for James Watson, an overtly racist eugenicist. Despite that, Lander is set to be confirmed by the Senate and Congress and is reportedly significantly enthusiastic about the proposed new “health DARPA.”

This new agency, set to be called ARPA-H or HARPA, would be housed within the National Institutes of Health (NIH) and would raise the NIH budget to over $51 billion. Unlike other agencies at NIH, ARPA-H would differ in that the projects it funds would not be peer reviewed prior to approval; instead hand-picked program managers would make all funding decisions. Funding would also take the form of milestone-driven payments instead of the more traditional multiyear grants.

ARPA-H will likely heavily fund and promote mRNA ναccιnєs as one of the “breakthroughs” that will cure cancer. Some of the mRNA ναccιnє manufacturers that have produced some of the most widely used CÖVÌD-19 ναccιnєs, such as the pfιzєr/BioNTech ναccιnє, stated just last month that “cancer is the next problem to tackle with mRNA tech” post-CÖVÌD. BioNTech has been developing mRNA gene therapies for cancer for years and is collaborating with the Bill & Melinda Gates Foundation to create mRNA-based treatments for tuberculosis and HIV.


 

Sitemap 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16